Chronic Kidney Disease-Associated Anemia Treatment: Scientific Advances for Healthcare Providers
Chronic Kidney Disease-Associated Anemia Treatment: Scientific Advances for Healthcare Providers is organized by American Association of Nurse Practitioners (AANP).
Release Date: 1/03/2023
Expiration Date: 06/20/2024
Overview:
The prevalence of anemia in CKD is more than twice the rate among patients with CKD compared to the general population, and increases from 8.4% in stage to 53.4% by stage 5. The addition of ESA and HIF-PF inhibitors have changed the options available for patients suffering from complications of this disease. NPs must be able to discuss the signs and symptoms of anemia and, in collaboration with the nephrology specialist team, determine and incorporate the most appropriate guideline-driven treatment option in a patient-centered, individualized approach.
Objectives:
• Discuss the pathophysiology and management of anemia of CKD.
• Illustrate the economic, health, and social burden of anemia of CKD among patients and caregivers.
• Dissect healthcare disparities that exist in the management of anemia of CKD.
• Evaluate the new science surrounding the pathogenesis of anemia of CKD and implications for disease management.
• Justify the rationale behind current standard-of-care recommendations for the management of anemia of CKD.